Login / Signup

Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?

Mustafa EkiciY BaytarAli AkdoğanGamze DurhanOrhan Macit ArıyürekUmut Kalyoncu
Published in: Scandinavian journal of rheumatology (2024)
Our findings indicate a negative association between methotrexate use and ILD progression. These results should be confirmed in further studies.
Keyphrases
  • interstitial lung disease
  • rheumatoid arthritis
  • systemic sclerosis
  • prognostic factors
  • idiopathic pulmonary fibrosis
  • high dose
  • disease activity
  • ankylosing spondylitis
  • case control
  • systemic lupus erythematosus